Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis

Journal of Thrombosis and Thrombolysis

Volumn 22, Issue 2, 2006, Pages 111-112

  Eroglu, Aydan ^a   Ulu, Arzu ^b   Akar, Nejat ^b  

^a Numune State Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Cancer; PAI 1; Thrombosis

Indexed keywords

GENOMIC DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DNA ISOLATION; FEMALE; FIBRINOLYSIS; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; STATISTICAL ANALYSIS; THROMBOSIS; VENOUS THROMBOEMBOLISM;

CASE-CONTROL STUDIES; FACTOR V; HUMANS; NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; RISK FACTORS; THROMBOSIS;

EID: 33749163676     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-9054-z     Document Type: Article

References (9)

1. Schulman S, Wiman B (1996) The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group. Thromb Haemost 75:607-611
2. Ny T, Sawdey M, Lawrence D, Millan JL, Loskutoff DJ (1986) Cloning and sequence of cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 83:6776-6780
3. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Bio Chem 268:10739-10745
4. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP (1997) Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 95:59-62
5. Varela ML, Adamczuk YP, Forestiero RR, et al. (2001) Major and potential prothrombotic genotype in a cohort of patients with venous thromboembolism. Thromb Res 104:317-324
6. Sartori MT, Danesin C, Saggiorato G, et al. (2003) The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost 9:299-307
7. Akar N, Yilmaz E, Akar E, Avcu F, Cin S (2000) Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV 1691 G-A. Thromb Res 97:227-230
8. Barcellona D, Fenu L, Cauli C, Pisu G, Marongiu F (2003) Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemost 90:1061-1064.
9. Eroglu A, Kurtman C, Ulu A, Cam R, Akar N (2005) Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis. J Thromb Haemost 3:1323-1324